beatandraise : Equity Research with AI and ChatGPT on SEC Edgar

beatandraise.com

No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Operating Leases, Future Minimum Payments Due, Retail Space. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Notional and Credit Risk Amounts of Outstanding Derivative Positions Disclosure. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of the changes in outstanding nonvested restricted stock units. No authoritative reference available. Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value. No authoritative reference available. No authoritative reference available. No authoritative reference available. The weighted average grant-date fair value of stock purchase rights granted during the reporting period as calculated by applying the disclosed option pricing methodology. No authoritative reference available. No authoritative reference available. No authoritative reference available. The minimum maturity period (in years) for the Company's long term marketable securities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Credit Risk Amount of Foreign Currency Derivative Instruments Designated as Hedging Instruments as of the balance sheet date. No authoritative reference available. Text block that encapsulates the detailed table comprising the condensed financial statements (balance sheet, income statement and statement of cash flows), normally using the registrant (parent) as the sole domain member. If condensed consolidating financial statements are being presented, other domain members (in addition to parent) such as guarantor subsidiaries, non-guarantor subsidiaries, and the consolidation eliminations, will be included in order that the respective monetary amounts for each of the domains will aggregate to the respective amounts on the consolidated financial statements. The line items are the various captions used to compile the condensed financial statements. Using extensions, most, if not all, of the elements representing condensed financial statement captions will be the same as those used for the consolidated financial statements captions. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of countries with Apple retail stores, including the U.S. No authoritative reference available. Describes the results of the Company's recent legal proceedings. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Describes an entity's accounting policy for determining the fair value of its financial instruments. No authoritative reference available. No authoritative reference available. No authoritative reference available. Purchase Commitment, Minimum Period Required (in days). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Carrying amount at the balance sheet date for long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, physical structures, machinery, vehicles, furniture, computer equipment, construction in progress, and similar items. Also includes software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization. Amount does not include depreciation. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Minimum period (in years) for Retail leases. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Reflects the amount of damages against the Company from a jury returned verdict. No loss contingency has been recorded as of the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Prepayment commitment to be paid at a future date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Fair value as of the balance sheet date of all foreign currency derivative assets designated as hedging instruments. No authoritative reference available. No authoritative reference available. No authoritative reference available. Outstanding off-balance sheet commitments for outsourced manufacturing and component purchases. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Accrued Marketing And Distribution, Current No authoritative reference available. No authoritative reference available. No authoritative reference available. Number of high profile stores open as of the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Accrued Warranties and Related Costs Table Disclosure. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Stock Based compensation expense associated to Selling, general and administrative expense No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. Also includes software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The (unrounded) quantity of shares issuable on stock options awarded under the plan during the reporting period. No authoritative reference available. Maximum period (in years) for Retail leases. No authoritative reference available. The maximum maturity period (in years) for the Company's long term marketable securities. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Stock Based compensation expense associated to cost of sales No authoritative reference available. No authoritative reference available. No authoritative reference available. Other corporate expenses include research and development, corporate marketing expenses, manufacturing costs and variances not included in standard costs, and other separately managed general and administrative expenses, including certain corporate expenses associated with support of the Retail segment. No authoritative reference available. The maximum term (in years) that the Company's major facility leases typically do not exceed. No authoritative reference available. No authoritative reference available. No authoritative reference available. Percentage of Total Non Trade Receivables No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The weighted-average period between the balance-sheet date and expiration date for options expected to vest, which may be expressed in a decimal value for number of years. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The entire disclosure for the basis of presentation, or accounting, and significant accounting policies. No authoritative reference available. Cash, Cash Equivalents and Marketable Securities Disclosure. No authoritative reference available. No authoritative reference available. No authoritative reference available. The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). No authoritative reference available. Cash paid by the entity during the period to satisfy tax withholding obligations associated with the net share settlement of equity instruments granted under share-based payment arrangements. No authoritative reference available. No authoritative reference available. No authoritative reference available. The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Also includes disclosure of compensation-related costs for equity-based compensation which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details, and employee stock purchase plan details. No authoritative reference available. The total intrinsic value of nonvested awards on share-based plans excluding option plans for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares, as calculated by applying the disclosed pricing methodology. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Comprehensive Income (Loss), Policy. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the gross unrealized gain on debt available for sale securities as of the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The maximum term (in years) that the renewal option terms on the Company's major facility leases typically do not exceed. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of vested portions of options outstanding and currently exercisable under the option plan as of the balance sheet date. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land. ) that has been recognized in the income statement. Also includes amortization of software programs or applications for internal use. No authoritative reference available. Machinery, Equipment and Internal Use Software Gross. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Schedule of Derivative Instruments, Effect on Income and Other Comprehensive Income. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of the components of accumulated other comprehensive income (loss). No authoritative reference available. Purchase Commitment, Maximum Period Required (in days). No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of components of comprehensive income (loss) including, but not limited to: (a) foreign currency translation adjustments; (b) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (c) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (d) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (e) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (f) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (g) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans. No authoritative reference available. No authoritative reference available. No authoritative reference available. Credit Risk Amount of Foreign Currency Derivative Instruments Not Designated as Hedging Instruments. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period. No authoritative reference available. No authoritative reference available. No authoritative reference available. This item represents the gross unrealized loss on debt available for sale securities as of the balance sheet date. No authoritative reference available. Stock Based compensation expense associated to research and development expense No authoritative reference available. No authoritative reference available. No authoritative reference available. Percentage of Total Trade Receivables No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Majority lease terms (in years) for Retail leases. No authoritative reference available. Total inventory component prepayments outstanding as of the balance sheet date. No authoritative reference available. Reconciliation of Operating Income from Segments to Consolidated. No authoritative reference available. The weighted average period between the balance sheet date and expiration for all awards outstanding under the plan, which may be expressed in a decimal value for number of years. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as hedging instruments. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. No authoritative reference available. No authoritative reference available. No authoritative reference available. Land and buildings, Gross No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Disclosure includes additional financial statement details for certain financial statement categories within the consolidated financial statements. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. No authoritative reference available. Aggregate notional amount, as of the balance sheet date, of all foreign currency derivatives designated as hedging instruments. Notional amount refers to the number of currency units specified in the foreign currency derivative contract. No authoritative reference available. No authoritative reference available. No authoritative reference available.